Press release – Collaboration with LCSB on Parkinson’s disease

Jun 18, 2018 | Press releases

Ksilink teams up with the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg to develop drugs to treat Parkinson’s disease. Together they will develop novel patient-based cell culture models in which they can automatically and with artificial intelligence (AI) test drug candidates from a large substance library. Click here to download the press release.

Share This